Cocaine ‘vaccine’: trials allowed in humans

Department of Genetic Medicine at Weill Cornell and NewYork-Presbyterian developed a vaccine to make cocaine less appealing to addicts – yesterday, they announced that the US Food and Drug Administration has allowed a clinical trial to move forward for study in humans.